The effects of glycine on auditory mismatch negativity in schizophrenia
در صورتی که مقاله لاتین مورد نظر شما تا کنون به زبان فارسی ترجمه نشده باشد، واحد ترجمه پایگاه ISI Articles با همکاری تنی چند از اساتید و مترجمان با سابقه، آمادگی دارد آن را در اسرع وقت و با کیفیت مطلوب برای شما ترجمه نماید.
Beck Self-Esteem Scale-Short Form: Development and psychometric evaluation of a scale for the assessment of self-concept in schizophrenia
Demographic and clinical characteristics associated with a history of bizarre delusions in a cross-diagnostic sample of individuals with psychotic disorders
Adjunctive therapy with statins in schizophrenia patients: A meta-analysis and implications
Do cognitive deficits predict negative emotionality and aggression in schizophrenia?
Assessing Social Affiliative Behavior: A Comparison of In Vivo and Video Tasks
The impact of self-stigmatization on medication attitude in schizophrenia patients
Effects of chlorpromazine on sleep quality, clinical and emotional measures among patients with schizophrenia
Pituitary volume reduction in schizophrenia following cognitive behavioural therapy
Clinical and demographic variables associated with coping and the burden of caregivers of schizophrenia patients
The role of experiential and expressive negative symptoms on job obtainment and work outcome in individuals with schizophrenia
Reduced cardiovascular fitness associated with exposure to clozapine in individuals with chronic schizophrenia
Serum zinc levels in acute psychiatric patients: A case series
Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study
Predictors of aggression in 3.322 patients with affective disorders and schizophrenia spectrum disorders evaluated in an emergency department setting
Emotion and self in psychotic disorders: Behavioral evidence from an emotional evaluation task using verbal stimuli varying in emotional valence and self-reference
Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis
Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders
Functional connectivity during affective mentalizing in criminal offenders with psychotic disorders: Associations with clinical symptoms
Validity of routine clinical diagnoses in acute psychiatric inpatients
A study to compare the differences between genders in psychiatric comorbidities in individuals with psychoses
Decision-making Capacity for Treatment of Psychotic Patients on Long Acting Injectable Antipsychotic Treatment
Risk of hospitalization for psychiatric disorders among siblings and parents of probands with psychotic or affective disorders: A population-based study
Associations of suicidality with cognitive ability and cognitive insight in outpatients with Schizophrenia
Deviation from expected cognitive ability across psychotic disorders
Interpersonal beliefs related to suicide and facial emotion processing in psychotic disorders
Clinical utility of biomarkers of the hand in the diagnosis of schizophrenia
Risk of gastrointestinal Hypomotility in schizophrenia and schizoaffective disorder treated with antipsychotics: A retrospective cohort study
Hippocampal activation and memory performance in schizophrenia depend on strategy use in a virtual maze
Comparison of Suicide Attempts/Behaviors Following Smoking Cessation Treatments Among Schizophrenic Smokers
Omega-3 fatty acids related to cognitive impairment in patients with schizophrenia
The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits
Gesture impairments in schizophrenia are linked to increased movement and prolonged motor planning and execution
Serious delinquency and later schizophrenia: A nationwide register-based follow-up study of Finnish pretrial 15- to 19-year-old offenders sent for a forensic psychiatric examination
Measuring learning potential in people with schizophrenia: A comparison of two tasks
Trends of Cannabis Use Disorder in the Inpatient: 2002 to 2011
Ethnicity and excess mortality in severe mental illness: a cohort study
Further evidence of alerted default network connectivity and association with theory of mind ability in schizophrenia
Level of functioning, perceived work ability, and work status among psychiatric patients with major mental disorders
Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects
Characterization of Admission Types in Medically Hospitalized Patients Prescribed Clozapine
Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder
Evaluating clinicians' representations of schizoaffective disorder
Characteristics and Service Use of Older Adults with Schizoaffective Disorder Versus Older Adults with Schizophrenia and Bipolar Disorder
Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care
How accurate are self-reported height and weight in the seriously mentally ill?
Gray Matter Neuritic Microstructure Deficits in Schizophrenia and Bipolar Disorder
Meta-analysis of adult height and birth length in schizophrenia
Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses
Neural complexity as a potential translational biomarker for psychosis
Motor dysfunction as an intermediate phenotype across schizophrenia and other psychotic disorders: Progress and perspectives
Cognitive burden of anticholinergic medications in psychotic disorders
Psychomotor assessment as a tool to differentiate schizophrenia from other psychotic disorders
Urinary tract infections in children and adolescents with acute psychosis
Altered growth trajectory of head circumference during infancy and schizophrenia in a National Birth Cohort
A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia
Gender matters in schizophrenia-spectrum disorders: Results from a healthcare users epidemiological study in Malaga, Spain
Determinants of Quality of Life in Spanish outpatients with schizophrenia spectrum disorders
The effects of perceptual load in processing emotional facial expression in psychotic disorders
Childhood trauma-related alterations in brain function during a Theory-of-Mind task in schizophrenia
Predictors of current functioning and functional decline in schizophrenia
Peripheral blood gene expression of acute phase proteins in people with first episode psychosis
Aspects of Theory of Mind that attenuate the relationship between persecutory delusions and social functioning in schizophrenia spectrum disorders
Impaired theta-gamma coupling during working memory performance in schizophrenia
The barriers to participation in leisure time physical activities among Iranian women with severe mental illness: A qualitative study
Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients
De novo cost-utility analysis of oral paliperidone in the treatment of schizoaffective disorder
Reliability and clinical correlates of the Astrand–Rhyming sub-maximal exercise test in patients with schizophrenia or schizoaffective disorder
Cost analysis of risperidone long-acting injection in the treatment of schizophrenia and schizoaffective disorders in Hong Kong: An approach using generalised estimating equations
The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: A randomized, double-blind, placebo-controlled trial ☆
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder ☆
Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: A randomized double-blind pilot trial